From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Upcoming Events

-
Online Controlled Substances Summit
Online Controlled Substances Summit Virtual Meeting Public Session: July 25, 2024 | 11am-3pm (eastern)
Real-World Evidence Webinar Series: Considerations Regarding Non-Interventional Studies for Drug and Biological Products
Real-World Evidence Webinar Series:
Natural History Studies and Registries in the Development of Rare Disease Treatments
Natural History Studies and Registries in the Development of Rare Disease Treatments Public Workshop: In-Person and Virtual
2024 Annual Public Meeting
Each yea

Past Events

Qualifying Biomarkers to Support Rare Disease Regulatory Pathways
Qualifying Biomarkers to Support Rare Disease Regulatory Pathways
-
Advancing Psychedelic Clinical Study Design
Advancing Psychedelic Clinical Study DesignVirtual Public Meeting Day 1: January 31, 2024 | 10am-2pm (eastern)
2023 Innovations in Regulatory Science Awards
Front-of-Package Nutrition Labeling
Front-of-Package Nutrition LabelingVirtual Public Meeting
Integrating Clinical Studies Into Health Care Delivery: Post-Market Evidence Generation for Medical Products
Integrating Clinical Studies Into Health Care Delivery: Post-Market Evidence Generation for Medical ProductsVirtual Public Meeting
Virtual Public Meeting: Strategies for Improving Public Understanding of FDA-Regulated Products
Strategies for Improving Public Understanding of FDA-Regulated Products Virtual Public Meeting
Public Meeting: Mitigating Risks from Human Xylazine Exposure
Mitigating Risks from Human Xylazine Exposure Public Meeting: In-person and Virtual 
-
Good Clinical Practice: Considerations for Trials with Pragmatic or Decentralized Features
On September 12 and 13, the Foundation, in collaboration with the U.S. Food and Drug Administration, hosted a webinar to explore Good Clinical Practice Considerations for Trials with Pragmatic or Decentralized Features.
RAISE Public Meeting: Lessons Learned & Practical Applications for the Future
RAISE: Lessons Learned & Practical Applications for the Future June 15, 2023 2-4 pm ET  
RAISE: Reactions to Barriers, Facilitators, and Proposed Solutions
RAISE: Reactions to Barriers, Facilitators, and Proposed Solutions Thursday, June 1, 2023 2-3 PM ET